157 related articles for article (PubMed ID: 34626894)
21. COL4A3 mutation is an independent risk factor for poor prognosis in children with Alport syndrome.
Ozdemir G; Gulhan B; Atayar E; Saygılı S; Soylemezoglu O; Ozcakar ZB; Eroglu FK; Candan C; Demir BK; Soylu A; Yüksel S; Alpay H; Agbas A; Duzova A; Hayran M; Ozaltin F; Topaloglu R
Pediatr Nephrol; 2020 Oct; 35(10):1941-1952. PubMed ID: 32394188
[TBL] [Abstract][Full Text] [Related]
22. Generation of an induced pluripotent stem cell line (SHCDNRi001-A) from a patient with X-linked Alport syndrome carrying a heterozygous p.G409S (c. 1225 G > A) mutation in the COL4A5 gene.
Sun L; Zhang J; Kuang XY; Kang YL; Wu Y; Huang WY
Stem Cell Res; 2020 May; 45():101833. PubMed ID: 32416580
[TBL] [Abstract][Full Text] [Related]
23. Autosomal recessive Alport syndrome: an in-depth clinical and molecular analysis of five families.
Longo I; Scala E; Mari F; Caselli R; Pescucci C; Mencarelli MA; Speciale C; Giani M; Bresin E; Caringella DA; Borochowitz ZU; Siriwardena K; Winship I; Renieri A; Meloni I
Nephrol Dial Transplant; 2006 Mar; 21(3):665-71. PubMed ID: 16338941
[TBL] [Abstract][Full Text] [Related]
24. Nine novel COL4A3 and COL4A4 mutations and polymorphisms identified in inherited membrane diseases.
Rana K; Tonna S; Wang YY; Sin L; Lin T; Shaw E; Mookerjee I; Savige J
Pediatr Nephrol; 2007 May; 22(5):652-7. PubMed ID: 17216251
[TBL] [Abstract][Full Text] [Related]
25. iPSC-derived type IV collagen α5-expressing kidney organoids model Alport syndrome.
Hirayama R; Toyohara K; Watanabe K; Otsuki T; Araoka T; Mae SI; Horinouchi T; Yamamura T; Okita K; Hotta A; Iijima K; Nozu K; Osafune K
Commun Biol; 2023 Sep; 6(1):854. PubMed ID: 37770589
[TBL] [Abstract][Full Text] [Related]
26. A novel COL4A3 mutation causes autosomal-recessive Alport syndrome in a large Turkish family.
Uzak AS; Tokgoz B; Dundar M; Tekin M
Genet Test Mol Biomarkers; 2013 Mar; 17(3):260-4. PubMed ID: 23297803
[TBL] [Abstract][Full Text] [Related]
27. A human-mouse chimera of the alpha3alpha4alpha5(IV) collagen protomer rescues the renal phenotype in Col4a3-/- Alport mice.
Heidet L; Borza DB; Jouin M; Sich M; Mattei MG; Sado Y; Hudson BG; Hastie N; Antignac C; Gubler MC
Am J Pathol; 2003 Oct; 163(4):1633-44. PubMed ID: 14507670
[TBL] [Abstract][Full Text] [Related]
28. Genotype-phenotype correlations in 17 Chinese patients with autosomal recessive Alport syndrome.
Zhang Y; Wang F; Ding J; Zhang H; Zhao D; Yu L; Xiao H; Yao Y; Zhong X; Wang S
Am J Med Genet A; 2012 Sep; 158A(9):2188-93. PubMed ID: 22887978
[TBL] [Abstract][Full Text] [Related]
29. A new mutation in the COL4A3 gene responsible for autosomal dominant Alport syndrome, which only generates hearing loss in some carriers.
Rosado C; Bueno E; Fraile P; García-Cosmes P; González-Sarmiento R
Eur J Med Genet; 2015 Jan; 58(1):35-8. PubMed ID: 25450602
[TBL] [Abstract][Full Text] [Related]
30. Mutation analysis of COL4A3 and COL4A4 genes in a Chinese autosomal-dominant Alport syndrome family.
Guo L; Li D; Dong S; Wan D; Yang B; Huang Y
J Genet; 2017 Jun; 96(2):389-392. PubMed ID: 28674241
[TBL] [Abstract][Full Text] [Related]
31. Novel COL4A3 mutations in African American siblings with autosomal recessive Alport syndrome.
Cook C; Friedrich CA; Baliga R
Am J Kidney Dis; 2008 May; 51(5):e25-8. PubMed ID: 18436078
[TBL] [Abstract][Full Text] [Related]
32. Deciphering the pathogenesis of the COL4-related hematuric nephritis: A genotype/phenotype study.
Uliana V; Sebastio P; Riva M; Carli D; Ruberto C; Bianchi L; Graziano C; Capelli I; Faletra F; Pillon R; Mattina T; Sensi A; Bonatti F; Percesepe A
Mol Genet Genomic Med; 2021 Feb; 9(2):e1576. PubMed ID: 33369211
[TBL] [Abstract][Full Text] [Related]
33. Generation of induced pluripotent stem cell line (NCKDi001-A) from a 19-year-old patient with a novel COL4A5 gene mutation in Alport syndrome.
Wang G; Wu H; Gao E; Zhang L; Chen L; Zhu Y; Zhang J; Liu Z
Stem Cell Res; 2020 Dec; 49():102023. PubMed ID: 33128955
[TBL] [Abstract][Full Text] [Related]
34. Generation of two induced pluripotent stem cell lines from patients with X-linked Alport syndrome.
Ma Y; Wang Z; Gao M; Liu X; Sun W; Gong Y; Sun G; Liu G
Stem Cell Res; 2021 May; 53():102343. PubMed ID: 33878711
[TBL] [Abstract][Full Text] [Related]
35. Alport syndrome: deducing the mode of inheritance from the presence of haematuria in family members.
Savige J
Pediatr Nephrol; 2020 Jan; 35(1):59-66. PubMed ID: 30506145
[TBL] [Abstract][Full Text] [Related]
36. Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.
Imafuku A; Nozu K; Sawa N; Hasegawa E; Hiramatsu R; Kawada M; Hoshino J; Tanaka K; Ishii Y; Takaichi K; Fujii T; Ohashi K; Iijima K; Ubara Y
Nephrology (Carlton); 2018 Oct; 23(10):940-947. PubMed ID: 28704582
[TBL] [Abstract][Full Text] [Related]
37. Pathogenic Variants in the Genes Affected in Alport Syndrome (COL4A3-COL4A5) and Their Association With Other Kidney Conditions: A Review.
Savige J; Harraka P
Am J Kidney Dis; 2021 Dec; 78(6):857-864. PubMed ID: 34245817
[TBL] [Abstract][Full Text] [Related]
38. Autosomal recessive Alport's syndrome and benign familial hematuria are collagen type IV diseases.
Tazón Vega B; Badenas C; Ars E; Lens X; Milà M; Darnell A; Torra R
Am J Kidney Dis; 2003 Nov; 42(5):952-9. PubMed ID: 14582039
[TBL] [Abstract][Full Text] [Related]
39. A mouse Col4a4 mutation causing Alport glomerulosclerosis with abnormal collagen α3α4α5(IV) trimers.
Korstanje R; Caputo CR; Doty RA; Cook SA; Bronson RT; Davisson MT; Miner JH
Kidney Int; 2014 Jun; 85(6):1461-8. PubMed ID: 24522496
[TBL] [Abstract][Full Text] [Related]
40. Evidence of digenic inheritance in Alport syndrome.
Mencarelli MA; Heidet L; Storey H; van Geel M; Knebelmann B; Fallerini C; Miglietti N; Antonucci MF; Cetta F; Sayer JA; van den Wijngaard A; Yau S; Mari F; Bruttini M; Ariani F; Dahan K; Smeets B; Antignac C; Flinter F; Renieri A
J Med Genet; 2015 Mar; 52(3):163-74. PubMed ID: 25575550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
